Suppr超能文献

耳霉菌病的临床表现、聚类分析及实验室研究——单中心经验

Clinical Presentations, Cluster Analysis and Laboratory-Based Investigation of Otomycosis-A Single Center Experience.

作者信息

Bojanović Mila, Ignjatović Aleksandra, Stalević Marko, Arsić-Arsenijević Valentina, Ranđelović Marina, Gerginić Vladimir, Stojanović-Radić Zorica, Stojković Ognjen, Živković-Marinkov Emilija, Otašević Suzana

机构信息

Medical Faculty, University of Niš, 18000 Niš, Serbia.

Clinic of Otorhinolaryngology, University Clinical Center Niš, 18000 Niš, Serbia.

出版信息

J Fungi (Basel). 2022 Mar 18;8(3):315. doi: 10.3390/jof8030315.

Abstract

Species of () complex and complex are predominant molds that are causative agents of otomycoses. The goal of this study was to investigate the clinical presentation, diagnostic procedure, and appearance of relapse in patients with -otomycosis, as well as to determine the biofilm production ability of species isolated in relapse. Thirty patients with laboratory evidenced -otomycosis followed by two check-ups (30 and 60 days after initiation of treatment with antimycotics for local application) were included in the study. For isolation and identification of spp. the standard mycological procedure was applied. Results showed very high sensitivity of microscopy, but 16.7% species required the optimal temperature of 27-28 °C for cultivation. Applied statistical cluster analysis showed a defined specific cluster/group of patients with complex-otomycosis. Sixty days after diagnosis and treatment initiation, six patients had a relapse, with the same species of genus being the cause. To establish the ability of biofilm production, the modified method described by Pierce and Kvasničková was performed, and all six species isolated in the relapse episode had the ability to produce biofilm. Official criteria and recommendations are needed due to the possibility of misdiagnosis, which leads to the prolongation and complication of the disease.

摘要

()复合体和复合体的物种是耳真菌病的主要致病霉菌。本研究的目的是调查耳真菌病患者的临床表现、诊断程序和复发情况,以及确定复发时分离出的物种的生物膜形成能力。30例经实验室证实患有耳真菌病并随后进行两次检查(局部应用抗真菌药物治疗开始后30天和60天)的患者被纳入研究。对于分离和鉴定 spp.,采用了标准的真菌学程序。结果显示显微镜检查的敏感性非常高,但16.7%的物种需要27 - 28°C的最佳温度进行培养。应用统计聚类分析显示了一组明确的患有复合体耳真菌病的特定患者群。诊断和治疗开始60天后,6例患者复发,病因是同一属的物种。为确定生物膜形成能力,采用了Pierce和Kvasničková描述的改良方法,复发期分离出的所有6个物种都有形成生物膜的能力。由于存在误诊的可能性,这会导致疾病的延长和并发症,因此需要官方标准和建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17ee/8948793/7da306d0cc38/jof-08-00315-g001.jpg

相似文献

4
Etiologic Agents of Otomycosis in the North-Western Area of Iran.
Jundishapur J Microbiol. 2015 Sep 8;8(9):e21776. doi: 10.5812/jjm.21776. eCollection 2015 Sep.
5
Species distribution patterns and epidemiological characteristics of otomycosis in Southeastern Serbia.
J Mycol Med. 2020 Sep;30(3):101011. doi: 10.1016/j.mycmed.2020.101011. Epub 2020 Jun 30.
6
Molecular Identification and Antifungal Susceptibility of Yeasts and Molds Isolated from Patients with Otomycosis.
Mycopathologia. 2021 May;186(2):245-257. doi: 10.1007/s11046-021-00537-1. Epub 2021 Mar 15.
9
Black aspergilli as causes of otomycosis in the era of molecular diagnostics, a mini-review.
J Mycol Med. 2022 May;32(2):101240. doi: 10.1016/j.mycmed.2021.101240. Epub 2021 Dec 28.
10

引用本文的文献

2
[Analysis of fungal infections of external auditory canal and its risk factors in patients with chronic otitis media].
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2025 Jan;39(1):57-60. doi: 10.13201/j.issn.2096-7993.2025.01.012.
3
Study on the microbial diversity of ear canal secretions from patients with otomycosis.
Front Surg. 2024 Feb 9;11:1277799. doi: 10.3389/fsurg.2024.1277799. eCollection 2024.
5
Relapsing otomycosis despite prolonged systemic antifungal therapy and resolution after topical voriconazole administration: A case report.
Med Mycol Case Rep. 2022 Dec 28;39:23-25. doi: 10.1016/j.mmcr.2022.12.006. eCollection 2023 Mar.
6
Poly-(lactic--glycolic) Acid Nanoparticles Entrapping Pterostilbene for Targeting Section .
Molecules. 2022 Aug 25;27(17):5424. doi: 10.3390/molecules27175424.

本文引用的文献

2
Black aspergilli as causes of otomycosis in the era of molecular diagnostics, a mini-review.
J Mycol Med. 2022 May;32(2):101240. doi: 10.1016/j.mycmed.2021.101240. Epub 2021 Dec 28.
4
Species distribution patterns and epidemiological characteristics of otomycosis in Southeastern Serbia.
J Mycol Med. 2020 Sep;30(3):101011. doi: 10.1016/j.mycmed.2020.101011. Epub 2020 Jun 30.
6
Identification of Fungal Pathogens in Otomycosis and Their Drug Sensitivity: Our Experience.
Int Arch Otorhinolaryngol. 2018 Oct;22(4):400-403. doi: 10.1055/s-0038-1626702. Epub 2018 Apr 12.
7
[Otomycosis: the modern view of etiology and management].
Vestn Otorinolaringol. 2018;83(1):48-51. doi: 10.17116/otorino201883148-51.
8
Otomycosis in immunocompetent patients: Clinical and mycological features. Our experience with 40 cases.
Clin Otolaryngol. 2018 Feb;43(1):373-377. doi: 10.1111/coa.12966. Epub 2017 Sep 18.
9
Comparison of the recovery rate of otomycosis using betadine and clotrimazole topical treatment.
Braz J Otorhinolaryngol. 2018 Jul-Aug;84(4):404-409. doi: 10.1016/j.bjorl.2017.04.004. Epub 2017 May 6.
10
Aspergillus fumigatus DBM 4057 biofilm formation is inhibited by chitosan, in contrast to baicalein and rhamnolipid.
World J Microbiol Biotechnol. 2016 Nov;32(11):187. doi: 10.1007/s11274-016-2146-9. Epub 2016 Sep 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验